|1.||Steck, Andreas J: 5 articles (09/2015 - 03/2003)|
|2.||Kawagashira, Yuichi: 4 articles (09/2015 - 09/2010)|
|3.||Sobue, Gen: 4 articles (09/2015 - 09/2010)|
|4.||Koike, Haruki: 4 articles (09/2015 - 09/2010)|
|5.||Kusunoki, Susumu: 4 articles (02/2015 - 09/2010)|
|6.||Nobile-Orazio, E: 4 articles (02/2013 - 04/2000)|
|7.||Love, Seth: 3 articles (04/2015 - 07/2013)|
|8.||Iijima, Masahiro: 3 articles (01/2015 - 09/2010)|
|9.||Katsuno, Masahisa: 3 articles (01/2015 - 09/2010)|
|10.||Marklund, Niklas: 3 articles (01/2014 - 12/2006)|
02/01/2015 - "Anti-myelin-associated-glycoprotein (MAG) neuropathy is an intractable autoimmune polyneuropathy. "
10/01/2013 - "Anti-myelin-associated glycoprotein (MAG) neuropathy is a primary demyelinating sensorimotor polyneuropathy that can be very debilitating and is known to be resistant to treatment. "
09/01/2009 - "ELISA is more sensitive than Western blot to diagnose anti-myelin-associated glycoprotein related polyneuropathy, although a positive serology may be found in other forms of polyneuropathy as well."
02/01/2009 - "Anti-myelin-associated glycoprotein (MAG) neuropathy is an antibody-mediated polyneuropathy. "
01/01/2001 - "We describe an association of MBCL with anti-myelin-associated glycoprotein (MAG) polyneuropathy in a 53-year-old male. "
|2.||Peripheral Nervous System Diseases (PNS Diseases)
03/01/2009 - "Patient A 56-year-old man with peripheral neuropathy diagnosed as anti-myelin-associated glycoprotein neuropathy. "
03/01/2003 - "We found one published case of Schnitzler's syndrome and myelin-associated glycoprotein reactive peripheral neuropathy. "
01/01/2009 - "Anti-myelin-associated glycoprotein peripheral neuropathy as the only presentation of low grade lymphoma: a case report."
01/01/2003 - "patients of any age with anti-Myelin Associated Glycoprotein antibody associated demyelinating peripheral neuropathy with monoclonal gammopathy of undetermined significance of any severity. "
03/01/1999 - "Autoimmune responses to the myelin-associated glycoprotein (MAG) are implicated in the immunopathogenesis of both multiple sclerosis (MS) and certain peripheral neuropathies. "
|3.||Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
04/01/2010 - "GBS, however, is still a serious disease with a mortality rate of 8% and 20% of the patients being unable to walk independently a year after onset For CIDP and related disorders such as multifocal motor neuropathy, and demyeinating neuropathy with anti-myelin-associated-glycoprotein (MAG) antibody, treatments should be based on individual pathophysiology. "
05/01/2009 - "Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), multifocal motor neuropathy (MMN), and anti-myelin-associated glycoprotein (anti-MAG) neuropathy are three demyelinating acquired neuropathies, with distinct responses to immunotherapy. "
05/01/2012 - "The main chronic autoimmune neuropathies include chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and anti-myelin-associated glycoprotein (MAG) demyelinating neuropathy. "
03/01/2012 - "A demyelinating pattern was observed in 15 patients, 10 having anti-myelin-associated glycoprotein (anti-MAG) antibodies and 5 having neuropathy related to chronic inflammatory demyelinating polyradiculoneuropathy. "
06/01/2008 - "These features are useful in differential diagnosis of POEMS syndrome from chronic inflammatory demyelinating polyneuropathy (CIDP) and neuropathy associated with anti-myelin-associated glycoprotein antibody. "
|4.||Inclusion Body Myositis
05/19/2004 - "In other controlled studies, IVIG produced a modest, variable, and transient but not statistically significant benefit in patients with inclusion body myositis and paraproteinemic anti-myelin-associated glycoprotein antibody demyelinating polyneuropathy. "
06/01/2004 - "In paraproteinemic IgM anti-MAG (myelin-associated glycoprotein) demyelinating polyneuropathies and inclusion body myositis (IBM), the benefit is variable, marginal, and not statistically significant. "
11/01/1999 - "The clinical efficacy of IVIg, based on controlled clinical trials conducted in patients with GBS, CIDP, multifocal motor neuropathy (MMN), DM, MG, LEMS, paraproteinemic IgM anti-myelin-associated glycoprotein (anti-MAG) demyelinating polyneuropathies, and inclusion body myositis is summarized and practical issues related to each disorder are addressed. "
|5.||Brain Injuries (Brain Injury)
01/01/2014 - "Following traumatic brain injury (TBI) in the rat, pharmacological neutralisation of the MAIs Nogo-A and myelin-associated glycoprotein (MAG) resulted in improved functional outcome. "
01/01/2008 - "We have studied the effects of the fluid percussion injury (FPI) model of traumatic brain injury (TBI) on protein levels of two myelin-associated molecules, myelin-associated glycoprotein (MAG) and Nogo-A, in the adult rat. "
12/01/2006 - "Tissue sparing and functional recovery following experimental traumatic brain injury is provided by treatment with an anti-myelin-associated glycoprotein antibody."
07/01/2010 - "Functional recovery is markedly restricted following traumatic brain injury (TBI), partly due to myelin-associated inhibitors including Nogo-A, myelin-associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein (OMgp), that all bind to the Nogo-66 receptor-1 (NgR1). "
09/10/2003 - "Oligodendrocyte-myelin glycoprotein (OMgp) is expressed on the surface of oligodendrocytes and neurones and is thought to inhibit axonal regeneration after brain injury in adult, like Nogo and myelin-associated glycoprotein (MAG). "
|1.||Immunoglobulin M (IgM)
|3.||Intravenous Immunoglobulins (IVIG)
|9.||Proteins (Proteins, Gene)
|4.||Transplantation (Transplant Recipients)